SynthesisCardiovascular drugs and therapy2026
Comparative Cardiovascular, Lipid, and Safety Effects of Lipid-Modifying Therapies in Diabetes: An Agent-, Class-, and Dose-Level Network Meta-Analysis.
Xudong Zhao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.